Lung Cancer: Early Detection, Molecular Profiling, and Novel Therapeutic Approaches

This chapter provides an updated synthesis of recent progress in lung cancer screening, diagnosis, and treatment, encompassing advances in low-dose CT-based early detection programs, comprehensive molecular and genomic tumor profiling, and the expanding role of targeted therapies and immune checkpoint inhibitors. It addresses current challenges in translating biomarker discoveries into clinical utility and evaluates emerging multimodal strategies that aim to improve outcomes across all stages of disease.